SI — Shoulder Innovations Income Statement
0.000.00%
- $278.34m
- $359.65m
- $31.62m
- 38
- 26
- 46
- 29
Annual income statement for Shoulder Innovations, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG |
Status: | Final | Final |
Revenue | ||
Total Revenue | 19.3 | 31.6 |
Cost of Revenue | ||
Gross Profit | 15.3 | 24.3 |
Selling / General / Administrative Expenses | ||
Research And Development | ||
Unusual Expense / Income | ||
Total Operating Expenses | 29 | 46.3 |
Operating Profit | -9.74 | -14.7 |
Total Net Non Operating Interest Income / Expense | ||
Total Net Non Operating Interest Income / Expense | ||
Other Net Non Operating Costs | ||
Net Income Before Taxes | -9.07 | -13.7 |
Provision for Income Taxes | ||
Net Income After Taxes | -9.07 | -13.7 |
Net Income Before Extraordinary Items | ||
Net Income | -9.07 | -13.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||
Income Available to Common Shareholders Including Extraordinary Items | ||
Diluted Net Income | -9.07 | -13.7 |
Diluted Weighted Average Shares | ||
Basic EPS Including Extraordinary Items | ||
Diluted EPS Including Extraordinary Items | ||
Diluted EPS Excluding Extraordinary Items | ||
Normalised Income Before Taxes | ||
Normalised Income After Taxes | ||
Normalised Income Available to Common Shareholders | ||
Diluted Normalised EPS | -0.504 | -0.677 |